NCT01781468 2025-01-27
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Alliance for Clinical Trials in Oncology
Phase 3 Completed
Clinical Trials
13 trialsNCT01032200 2021-09-28
Armodafinil in Treating Fatigue Caused By Radiation Therapy in Patients With Primary Brain Tumors
Wake Forest University Health Sciences
Phase 2 Completed
NCT01381718 2021-08-13
Modafinil in Treating Children With Memory and Attention Problems Caused by Cancer Treatment for a Brain Tumor
University of South Florida
Phase 2 Completed
NCT00418691 2020-09-23
Effects of Methylphenidate Versus Sustained Release Methylphenidate on Cognitive Functioning
M.D. Anderson Cancer Center
Phase 3 Terminated
NCT01317550 2020-02-10
A Study for Reducing Symptom Burden Produced by Chemoradiation Treatment for Non Small Cell Lung Cancer by Minocycline and Armodafinil
M.D. Anderson Cancer Center
Phase NA Completed
NCT01011218 2018-11-29
Management of Insomnia in Breast Cancer Patients
Stanford University
Phase 2 Completed
NCT01746043 2018-06-06
A Phase II Study of Minocycline and Armodafinil for Reducing the Symptom Burden Produced by Chemoradiation Treatment for Esophageal Cancer
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00825227 2017-11-17
Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents
Teva Branded Pharmaceutical Products R&D, Inc.
Phase 2 Terminated
NCT00766467 2016-07-28
A Randomized Placebo-Controlled Trial of Armodafinil (Nuvigil) for Fatigue in Patients With Malignant Gliomas
Dana-Farber Cancer Institute
Phase 2 Completed
NCT01169753 2015-12-08
Nuvigil in Treatment of Cancer-Related Fatigue in Chronic Myeloid Leukemia Patients
M.D. Anderson Cancer Center
Phase NA Terminated
NCT01160380 2014-11-06
A Study of the Effectiveness of Armodafinil to Treat Cancer-Related Fatigue in Patients With Multiple Myeloma
Oncotherapeutics
Phase 3 Completed
NCT01348607 2014-02-21
Methylphenidate HCl or Modafinil in Treating Young Patients With Excessive Daytime Sleepiness After Cancer Therapy
University of South Florida
Phase 2 Terminated
NCT01400958 2013-12-16
Nuvigil or Placebo in Newly Diagnosed Malignant Glioma
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Terminated